The Harvard Drug Group LLC recalls

4 recalls.

• Carton Label: MAJOR recall (The Harvard Drug Group LLC)
  DrugClass IIReported July 1, 2026 · Subpotent Drug
• Omega-3-Acid recall (The Harvard Drug Group LLC)
  DrugClass IIReported April 29, 2026 · Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.
• Memantine Hydrochloride Extended-Release recall (The Harvard Drug Group LLC)
  DrugClass IIReported April 22, 2026 · Failed Dissolution Specifications
• Midodrine Hydrochloride Tablets recall (The Harvard Drug Group LLC)
  DrugClass IIReported March 11, 2026 · Defective container; inadequately sealed blister packaging.